Lousiana State University Health Sciences Center New Orleans (LSUHSC) educates Louisiana’s health care professionals. The state’s academic health leader, LSUHSC comprises a School of Medicine, the state’s only School of Dentistry, Louisiana’s only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. Louisiana’s flagship academic health center, LSUHSC faculty takes care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSUHSC research enterprise generates jobs and enormous economic impact. LSUHSC faculty have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease.
LSUHSC’s Louisiana Tumor Registry is one of the 18 competitively awarded cancer registries in the SEER (Surveillance, Epidemiology and End Results) Program of the National Cancer Institute. The SEER Program is the most authoritative source of information on cancer incidence and survival in the United States.
LSUHSC Cancer Center researchers have submitted two major patents, one aimed at controlling the growth of viruses with a newly discovered natural enzyme. This discovery could be applied for the prevention and treatment of infections such as the new forms of influenza and the prevention of cancer. The second patent is the development of a new mouse containing the human immune system, which allows investigators to use this mouse model to test new forms of immune therapies in cancer and other diseases. Both discoveries have been favorably evaluated for funding at the National Institutes of Health.
LSUHSC Cancer Center researchers discovered how an enzyme produced by cells of the immune system can be used in the treatment of T cell leukemias, an aggressive type of leukemia that is particularly difficult to treat in adult patients. They are now testing this new treatment for solid tumors of the lung and liver.
LSUHSC Cancer Center scientists have revealed, for the first time, the inner workings of a master gene regulator. It controls functions as diverse as the ability of nerve cells to “rewire” themselves in response to external stimuli and the mechanism by which certain viruses hijack the normal response of the immune system. Viruses can then replicate inside the cells ultimately leading to cancer.
LSUHSC Cancer Center researchers have shown that a master gene controlling how fast cancer cells divide is also essential in regulating the immune response to cancer.
The LSUHSC Viruses and Cancer Group received coveted admission to the AIDS Malignancy Consortium (AMC) funded by the National Cancer Institute. This consortium develops and makes available state-of-the-art cancer treatment for patients with HIV-AIDS and cancer who require specialized care. The LSUHSC Viruses and Cancer Group is the only member of the AMC in the Deep South.
LSUHSC researchers also developed one of the world’s most successful pediatric weight management programs, cited by the National Cancer Institute as a gold standard for risk reduction.
They also conducted a landmark study showing that second-hand smoke can cause lung cancer in people who have never smoked. These findings led the Environmental Protection Agency to designate second-hand smoke as a Class A carcinogen.